Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 192.74 Million CNY | 15.14% |
| 2022 | 177.02 Million CNY | 13.69% |
| 2021 | 176.56 Million CNY | 184.99% |
| 2020 | -276.04 Million CNY | -75.29% |
| 2019 | 177.82 Million CNY | 27.95% |
| 2018 | 172.78 Million CNY | -17.02% |
| 2017 | 192.47 Million CNY | -13.61% |
| 2016 | 258.09 Million CNY | -12.01% |
| 2015 | 297.61 Million CNY | 22.46% |
| 2014 | 246.02 Million CNY | 47.87% |
| 2013 | 163.34 Million CNY | 541.86% |
| 2012 | 110.63 Million CNY | -11.61% |
| 2011 | 32.01 Million CNY | 156.42% |
| 2010 | 19.22 Million CNY | -76.44% |
| 2009 | 15.7 Million CNY | 165.49% |
| 2008 | 17.66 Million CNY | 3.03% |
| 2007 | 17.56 Million CNY | -24.02% |
| 2006 | 24.18 Million CNY | -16.63% |
| 2005 | 29.06 Million CNY | -22.16% |
| 2004 | 37.42 Million CNY | 314.75% |
| 2003 | -17.38 Million CNY | 81.09% |
| 2002 | -59.82 Million CNY | -168.72% |
| 2001 | -34.21 Million CNY | -209.07% |
| 2000 | 20.06 Million CNY | 1900.88% |
| 1999 | 1.56 Million CNY | -86.5% |
| 1998 | 11.6 Million CNY | 1915.54% |
| 1997 | 236.37 Thousand CNY | -71.09% |
| 1996 | 1.99 Million CNY | 183.23% |
| 1995 | 703.47 Thousand CNY | 100.34% |
| 1994 | -205.13 Million CNY | -824.0% |
| 1993 | 28.33 Million CNY | 19.34% |
| 1992 | 23.74 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 31.4 Million CNY | -28.77% |
| 2024 Q3 | 28 Million CNY | -25.19% |
| 2024 Q1 | 34.16 Million CNY | 97.81% |
| 2023 Q3 | 32.92 Million CNY | 9.53% |
| 2023 Q1 | 37.9 Million CNY | 1015.11% |
| 2023 Q2 | 30.06 Million CNY | -20.69% |
| 2023 FY | - CNY | 15.14% |
| 2023 Q4 | 19.22 Million CNY | -41.62% |
| 2022 Q4 | 3.39 Million CNY | -92.44% |
| 2022 Q2 | 21.01 Million CNY | -41.79% |
| 2022 Q3 | 44.97 Million CNY | 114.02% |
| 2022 FY | - CNY | 13.69% |
| 2022 Q1 | 36.09 Million CNY | 2096.57% |
| 2021 Q2 | 34.05 Million CNY | 4.14% |
| 2021 Q1 | 32.7 Million CNY | 186.53% |
| 2021 FY | - CNY | 184.99% |
| 2021 Q3 | 46.54 Million CNY | 36.66% |
| 2021 Q4 | -1.8 Million CNY | -103.88% |
| 2020 Q1 | 22.91 Million CNY | -72.61% |
| 2020 Q2 | 29.03 Million CNY | 26.72% |
| 2020 Q3 | -5.28 Million CNY | -118.2% |
| 2020 Q4 | -37.79 Million CNY | -615.28% |
| 2020 FY | - CNY | -75.29% |
| 2019 FY | - CNY | 27.95% |
| 2019 Q4 | 83.67 Million CNY | 129.65% |
| 2019 Q3 | 36.43 Million CNY | -21.82% |
| 2019 Q2 | 46.6 Million CNY | 55.19% |
| 2019 Q1 | 30.03 Million CNY | -57.0% |
| 2018 Q3 | 5.95 Million CNY | -84.45% |
| 2018 Q4 | 69.84 Million CNY | 1073.62% |
| 2018 FY | - CNY | -17.02% |
| 2018 Q1 | 34.34 Million CNY | -58.45% |
| 2018 Q2 | 38.27 Million CNY | 11.43% |
| 2017 Q2 | 28.96 Million CNY | -7.06% |
| 2017 Q3 | 48.64 Million CNY | 67.96% |
| 2017 Q4 | 82.65 Million CNY | 69.92% |
| 2017 FY | - CNY | -13.61% |
| 2017 Q1 | 31.15 Million CNY | -69.29% |
| 2016 Q3 | 34.57 Million CNY | -22.48% |
| 2016 Q2 | 44.6 Million CNY | -0.48% |
| 2016 FY | - CNY | -12.01% |
| 2016 Q4 | 101.46 Million CNY | 193.43% |
| 2016 Q1 | 44.81 Million CNY | -49.81% |
| 2015 Q2 | 68.5 Million CNY | 28.86% |
| 2015 Q1 | 53.16 Million CNY | -4.48% |
| 2015 FY | - CNY | 22.46% |
| 2015 Q4 | 89.29 Million CNY | 42.78% |
| 2015 Q3 | 62.54 Million CNY | -8.7% |
| 2014 Q4 | 55.65 Million CNY | 2.63% |
| 2014 FY | - CNY | 47.87% |
| 2014 Q2 | 72.18 Million CNY | 95.76% |
| 2014 Q1 | 36.87 Million CNY | -53.85% |
| 2014 Q3 | 54.22 Million CNY | -24.88% |
| 2013 Q3 | 13.39 Million CNY | -74.89% |
| 2013 FY | - CNY | 541.86% |
| 2013 Q4 | 79.91 Million CNY | 496.48% |
| 2013 Q1 | 7.35 Million CNY | 127.92% |
| 2013 Q2 | 53.34 Million CNY | 625.66% |
| 2012 Q2 | 12.13 Million CNY | 126.85% |
| 2012 Q3 | -3.01 Million CNY | -124.82% |
| 2012 Q4 | 3.22 Million CNY | 207.09% |
| 2012 FY | - CNY | -11.61% |
| 2012 Q1 | 5.34 Million CNY | 7.02% |
| 2011 FY | - CNY | 156.42% |
| 2011 Q4 | 4.99 Million CNY | 235.74% |
| 2011 Q3 | -3.68 Million CNY | -138.94% |
| 2011 Q2 | 9.45 Million CNY | 13.35% |
| 2011 Q1 | 8.34 Million CNY | 149.85% |
| 2010 Q3 | -217.76 Thousand CNY | -101.55% |
| 2010 Q1 | 4.77 Million CNY | -81.78% |
| 2010 Q2 | 14.05 Million CNY | 194.69% |
| 2010 FY | - CNY | -76.44% |
| 2010 Q4 | -16.73 Million CNY | -7585.22% |
| 2009 Q2 | 9.89 Million CNY | 2892.98% |
| 2009 FY | - CNY | 165.49% |
| 2009 Q4 | 26.18 Million CNY | 1023.63% |
| 2009 Q3 | 2.33 Million CNY | -76.44% |
| 2009 Q1 | 330.45 Thousand CNY | 106.25% |
| 2008 Q3 | 8.9 Million CNY | 80.25% |
| 2008 FY | - CNY | 3.03% |
| 2008 Q1 | 1.48 Million CNY | -53.47% |
| 2008 Q2 | 4.94 Million CNY | 231.94% |
| 2008 Q4 | -5.28 Million CNY | -159.3% |
| 2007 Q1 | 1.28 Million CNY | -75.7% |
| 2007 Q4 | 3.2 Million CNY | 981.31% |
| 2007 Q3 | -363.14 Thousand CNY | -109.22% |
| 2007 Q2 | 3.93 Million CNY | 205.56% |
| 2007 FY | - CNY | -24.02% |
| 2006 Q2 | 9.69 Million CNY | 86.01% |
| 2006 Q3 | 4.22 Million CNY | -56.39% |
| 2006 Q4 | 5.3 Million CNY | 25.5% |
| 2006 FY | - CNY | -16.63% |
| 2006 Q1 | 5.21 Million CNY | 87.31% |
| 2005 Q4 | 2.78 Million CNY | -65.81% |
| 2005 Q1 | 7.38 Million CNY | -47.35% |
| 2005 Q2 | 11.37 Million CNY | 53.98% |
| 2005 Q3 | 8.13 Million CNY | -28.43% |
| 2005 FY | - CNY | -22.16% |
| 2004 FY | - CNY | 314.75% |
| 2004 Q1 | 914.18 Thousand CNY | 105.06% |
| 2004 Q2 | 16.79 Million CNY | 1737.51% |
| 2004 Q3 | 6.95 Million CNY | -58.57% |
| 2004 Q4 | 14.02 Million CNY | 101.58% |
| 2003 Q2 | -4.64 Million CNY | -116.66% |
| 2003 Q4 | -18.05 Million CNY | -972.12% |
| 2003 Q1 | -4.89 Million CNY | 97.54% |
| 2003 Q3 | 2.06 Million CNY | 144.52% |
| 2003 FY | - CNY | 81.09% |
| 2002 Q3 | 4.69 Million CNY | 142.59% |
| 2002 FY | - CNY | -168.72% |
| 2002 Q1 | -3.39 Million CNY | 0.0% |
| 2002 Q2 | -11.01 Million CNY | -224.55% |
| 2002 Q4 | -87.11 Million CNY | -1956.74% |
| 2001 FY | - CNY | -209.07% |
| 2000 FY | - CNY | 1900.88% |
| 1999 FY | - CNY | -86.5% |
| 1998 FY | - CNY | 1915.54% |
| 1997 FY | - CNY | -71.09% |
| 1996 FY | - CNY | 183.23% |
| 1995 FY | - CNY | 100.34% |
| 1994 FY | - CNY | -824.0% |
| 1993 FY | - CNY | 19.34% |
| 1992 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 96.521% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 94.609% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | 82.919% |
| Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 137.811% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | 1465.863% |
| NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | 88.097% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | -22.038% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | 87.62% |